Elevated serum chemokine CXC ligand 5 levels are associated with hypercholesterolemia but not a worsening of insulin resistance in Chinese people - PubMed (original) (raw)
. 2010 Aug;95(8):3926-32.
doi: 10.1210/jc.2009-2194. Epub 2010 May 25.
Zhaoyun Zhang, Jie Wen, Xuanchun Wang, Bin Lu, Zhihong Yang, Weiwei Zhang, Mei Wang, Xiaocheng Feng, Charlotte Ling, Songhua Wu, Renming Hu
Affiliations
- PMID: 20501684
- DOI: 10.1210/jc.2009-2194
Elevated serum chemokine CXC ligand 5 levels are associated with hypercholesterolemia but not a worsening of insulin resistance in Chinese people
Zhen Yang et al. J Clin Endocrinol Metab. 2010 Aug.
Abstract
Objective: Recent study showed high chemokine CXC ligand 5 (CXCL5) is thought to be associated with insulin resistance in humans. However, evidence from large-scale populations about the relationship between serum CXCL5 level and metabolic phenotypes is scarce. Here we sought to evaluate serum CXCL5 distribution and its association with metabolic phenotypes among middle-aged and older Chinese.
Research design and methods: We evaluated serum CXCL5 in a cross-sectional sample of 3225 Chinese aged from 50 to 88 yr in a Shanghai downtown district by ELISA. Glucose, insulin, lipid profile, inflammatory marker, and adipokine were also measured.
Results: The crude mean of serum CXCL5 concentrations were 1493.31 pg/ml for men and 2059.42 pg/ml for women (P<0.001), respectively. After multiple adjustment, the odds ratios were substantially higher for hypercholesterolemia (odds ratio 3.26, 95% confidence interval 2.36-4.51) in the highest CXCL5 quartile compared with those in the lowest quartile. These associations remained significant after further adjustment for body mass index, body fat, inflammatory marker, and adipokine. However, serum resistin CXCL5 was not associated with body mass index, percent body fat, fasting glucose, insulin levels, and homeostasis model assessment index-insulin resistance (r=0.01, 0.01, 0.01, 0.04, and 0.03, respectively; all P>0.05).
Conclusions: Elevated circulating CXCL5 concentrations were associated with higher risk of hypercholesterolemia in middle-aged and elderly Chinese independent of obesity, inflammation, adipokines, and other risk factors but not insulin resistance.
Similar articles
- Lipocalin-2, glucose metabolism and chronic low-grade systemic inflammation in Chinese people.
Huang Y, Yang Z, Ye Z, Li Q, Wen J, Tao X, Chen L, He M, Wang X, Lu B, Zhang Z, Zhang W, Qu S, Hu R. Huang Y, et al. Cardiovasc Diabetol. 2012 Jan 31;11:11. doi: 10.1186/1475-2840-11-11. Cardiovasc Diabetol. 2012. PMID: 22292925 Free PMC article. - Osteocalcin, glucose metabolism, lipid profile and chronic low-grade inflammation in middle-aged and elderly Chinese.
Chen L, Li Q, Yang Z, Ye Z, Huang Y, He M, Wen J, Wang X, Lu B, Hu J, Liu C, Ling C, Qu S, Hu R. Chen L, et al. Diabet Med. 2013 Mar;30(3):309-17. doi: 10.1111/j.1464-5491.2012.03769.x. Diabet Med. 2013. PMID: 22913521 - Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people.
Qi Q, Yu Z, Ye X, Zhao F, Huang P, Hu FB, Franco OH, Wang J, Li H, Liu Y, Lin X. Qi Q, et al. J Clin Endocrinol Metab. 2007 Dec;92(12):4827-34. doi: 10.1210/jc.2007-1219. Epub 2007 Sep 18. J Clin Endocrinol Metab. 2007. PMID: 17878249 - Inflammatory cytokines and metabolic risk factors during growth and maturation: influence of physical activity.
Rubin DA, Hackney AC. Rubin DA, et al. Med Sport Sci. 2010;55:43-55. doi: 10.1159/000321971. Epub 2010 Oct 14. Med Sport Sci. 2010. PMID: 20956859 Review. - Mechanistic role of CXCL5 in cardiovascular disease, diabetes mellitus, and kidney disease.
Chen C, Chang TT, Chen JW. Chen C, et al. Life Sci. 2023 Oct 1;330:122018. doi: 10.1016/j.lfs.2023.122018. Epub 2023 Aug 9. Life Sci. 2023. PMID: 37567498 Review.
Cited by
- Antidiabetic Properties of Chitosan and Its Derivatives.
Tzeng HP, Liu SH, Chiang MT. Tzeng HP, et al. Mar Drugs. 2022 Dec 17;20(12):784. doi: 10.3390/md20120784. Mar Drugs. 2022. PMID: 36547931 Free PMC article. Review. - Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery Disease.
Ravi S, Schuck RN, Hilliard E, Lee CR, Dai X, Lenhart K, Willis MS, Jensen BC, Stouffer GA, Patterson C, Schisler JC. Ravi S, et al. Am J Pathol. 2017 Dec;187(12):2895-2911. doi: 10.1016/j.ajpath.2017.08.006. Epub 2017 Nov 16. Am J Pathol. 2017. PMID: 29153655 Free PMC article. - Effects of purified anthocyanin supplementation on platelet chemokines in hypocholesterolemic individuals: a randomized controlled trial.
Zhang X, Zhu Y, Song F, Yao Y, Ya F, Li D, Ling W, Yang Y. Zhang X, et al. Nutr Metab (Lond). 2016 Nov 25;13:86. doi: 10.1186/s12986-016-0146-2. eCollection 2016. Nutr Metab (Lond). 2016. PMID: 27933092 Free PMC article. - Metabolic syndrome and osteoporotic fracture: a population-based study in China.
Qin L, Yang Z, Zhang W, Gu H, Li X, Zhu L, Lu S, Xing Y, Zhang H, Niu Y, Ning G, Su Q. Qin L, et al. BMC Endocr Disord. 2016 May 27;16(1):27. doi: 10.1186/s12902-016-0106-x. BMC Endocr Disord. 2016. PMID: 27233999 Free PMC article. - Large-Scale and Comprehensive Immune Profiling and Functional Analysis of Normal Human Aging.
Whiting CC, Siebert J, Newman AM, Du HW, Alizadeh AA, Goronzy J, Weyand CM, Krishnan E, Fathman CG, Maecker HT. Whiting CC, et al. PLoS One. 2015 Jul 21;10(7):e0133627. doi: 10.1371/journal.pone.0133627. eCollection 2015. PLoS One. 2015. PMID: 26197454 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical